pharmaceuticals
Granules India Limited Q3 FY23; PAT Jumped Up To 124 Crore
Granules India Limited (NSE: GRANULES) reported Revenue from Operations for Q3 FY23 of ₹1,146.12 Crore up from ₹996.76 Crore year…
Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%
Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of ₹1,533.22 Crores, a boost of 18% growth from the…
Laurus Labs Limited Q3 FY23; Consolidated Revenue Jumps By 50%
Laurus Labs Limited (NSE: LAURUSLABS) reported Revenue from Operations for Q3 FY23 of ₹1,544.82 Crore up from ₹1028.76 Crore year…
Infographic Ltd.(NSE: DRREDDY) | Q3 FY23 Results | Total Income rises +7.47% qoq
Dr. Reddy's Laboratories (NSE: DRREDDY) is an Indian multinational pharmaceutical company. Founded in 1984, the company primarily develops and sells…
Infographic Cipla Ltd.(NSE: CIPLA) | Q3 FY23 Results | Total Income falls -0.45% qoq
Cipla Limited (NSE: CIPLA) is an Indian multinational pharmaceutical and biopharmaceutical company. Founded in 1935, Cipla primarily develops and sells…
Gland Pharma Limited Q3 FY23; Net Profit Down To 232 Crore
Gland Pharma Limited (NSE: GLAND) reported Revenue from Operations of ₹938.28 Crore down from ₹1,063.32 Crore year on year, a…